Fortunately, an AhR agonist, Tapinarof cream 1%, has been approved in the USA to treat plaque psoriasis in adults, and is under investigation for the treatment of atopic dermatitis [39], indicating that the development of AhR agonists with fewer side effects could be achieved. Here, AHR is linked to atopic eczema.